Table III.
Pharmacotherapy recommended to patients with NAFLD
| Pharmacotherapy recommended to patients with NAFLD | N | % |
|---|---|---|
| Statins | 614 | 46.4 |
| Essential phospholipids (EPL) | 645 | 48.8 |
| Ursodeoxycholic acid (UDCA) | 633 | 47.9 |
| Vitamin E | 342 | 25.9 |
| ω-3 fatty acids | 222 | 16.8 |
| Thiazolidinediones | 50 | 3.8 |
| Others, e.g. milk thistle extract, L-ornithine L-aspartate, thiazolidine carboxylic acid | 655 | 49.5 |
| I do not recommend any drugs | 121 | 9.2 |